Navigation Links
DrugRisk Announces Latest Ruling By Judicial Panel on NuvaRing Lawsuits
Date:6/14/2013

Kansas City, MO (PRWEB) June 14, 2013

The birth control safety advocates at DrugRisk.com are announcing new information on the site for women who have used the vaginal ring contraceptive NuvaRing. A federal panel recently ruled that five patients filing cases in California alleging blood clot injuries will have to join the multi-district litigation in Missouri*.

DrugRisk was created to improve the safety of patients using popular prescription drugs and devices by providing the latest warnings, research, legal news and recalls. Visitors can find out if others are experiencing similar side effects and decide if they need legal advice.

Health experts have linked contraceptives like NuvaRing to higher risks of blood clots than traditional birth control pills. Last year, the New England Journal of Medicine published a study finding vaginal ring contraceptives could relate to a 2.5 to 3-fold increased risk of blood clots**.

With over a thousand patients filing a NuvaRing lawsuit alleging blood clots, many cases were consolidated to a special federal court in Missouri. The formal case is known as In re: NuvaRing Products Liability Litigation, No. 08-md-1964, JPML, Eastern District Missouri.

Recently, DrugRisk learned that five patients filed claims in Illinois*** and others attempted to have their cases heard in California*. However, the Judicial Panel on Multidistrict Litigation has ordered that the cases be combined with the current litigation in Missouri, where trials are scheduled to start in October****.

Anyone who suffered a blood clot, stroke, DVT or pulmonary embolism after using NuvaRing is urged to contact the DrugRisk Resource Center or speak with a lawyer about their legal rights as soon as possible.

Due to the specialized nature of federal MDL drug injury cases, DrugRisk only recommends lawyers and law firms who have already handled NuvaRing lawsuits.

For more information on the research, side effects and litigation news related to NuvaRing and other drugs, or to speak with a lawyer, visit http://www.DrugRisk.com.

*JPML 6/7/13; jpml.uscourts.gov/sites/jpml/files/MDL-1964-Tag-Along_Transfer-05-13.pdf
**New England Journal of Medicine, 6/14/12; nejm.org/doi/full/10.1056/NEJMoa1111840
***Madison Record, 6/6/13; madisonrecord.com/issues/895-product-liability/256335-five-federal-suits-filed-over-nuvaring-could-be-potential-tag-along-actions-to-missouri-mdl
****U.S. District Judge Rodney Sippel, 3/8/13; cdn.aboutlawsuits.com/wp-content/uploads/2013-03-08-NuvaRing-Order.pdf

Read the full story at http://www.prweb.com/releases/2013-nuvaring-lawsuit/mdl-litigation-news/prweb10831005.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DrugRisk Announces Drop in Yaz Lawsuits As Bayer Commits $1.5 Billion to Settlements
2. DrugRisks Announces Yaz Center With Latest Updates on Blood Clot Warnings and Settlements
3. DrugRisks Update: New Study Warns of Pradaxa Brain Bleeding
4. DrugRisk Update Shows Increase in NuvaRing Blood Clot Lawsuits
5. Latest Court Records Show 6% Increase In NuvaRing Lawsuits, DrugRisks Notes
6. DrugRisk News: Federal Panel Issues Latest Mirena Lawsuit Updates
7. DrugRisks Update: Latest Court Figures Show Rise In Pradaxa Lawsuits
8. DrugRisks Update: Yaz Class Action Begins in Canada as Settlements Continue in U.S.
9. DrugRisk Update: Byetta Maker Agrees With Transferring Lawsuits to Federal Court
10. DrugRisks Update: Warning Added to Pradaxa For Blood Condition
11. DrugRisks Update: Use of NuvaRing Drops Amid Injury Allegations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2017)... New York, NY (PRWEB) , ... May 26, 2017 , ... ... "Skin Health & Wound Care" campaign in USA Today, which will educate readers on ... Health side of the campaign, a large focus is placed on melanoma. Dancing with ...
(Date:5/26/2017)... ... May 26, 2017 , ... ... CareFusion NOX-T3 portable sleep monitor with its Somnoware Sleep Device Interface (SDI). Somnoware ... for diagnostic device operations. With this platform, initializing devices and importing studies are ...
(Date:5/26/2017)... ... May 26, 2017 , ... After raising nearly $30,000 on Kickstarter ... to be available at a discounted crowdfunding price on Indiegogo . , “Along ... I also wanted to bring a fidget toy to the market that was made ...
(Date:5/26/2017)... ... May 26, 2017 , ... “When the Stars Lead Home”: a poignant ... of published author Laura Weigel Douglas, an avid reader who lives in the Pacific ... sometimes feels like Green Hills Adventure Camp. She couldn’t be more grateful. , Twelve-year ...
(Date:5/26/2017)... , ... May 26, 2017 , ... Water damage to ... New Jersey School District had left education officials with a number of critical issues ... of the flooring had to be accomplished with little or no disruption to class ...
Breaking Medicine News(10 mins):
(Date:5/15/2017)... PHILADELPHIA , May 15, 2017 Enterin Inc., ... and developing novel compounds to treat Parkinson,s disease ... The study is a Phase 1/2a randomized, controlled, multicenter study ... sites. It will enroll 50 patients over a 9-to-12-month period. ... doses in 10 patients with PD. Participating sites include ...
(Date:5/10/2017)... WASHINGTON , May 10, 2017  The ... doctors or employees of sleep therapy clinics to ... a sleep therapy clinic is involved in a ... as interested in hearing from an employee of ... involved in a kickback scheme to provide medical practice ...
(Date:5/9/2017)... , May 9, 2017  Oramed Pharmaceuticals ... ), a clinical-stage pharmaceutical company focused on the ... that the Canadian Intellectual Property Office has granted ... Oral Administration of Exenatide". The patent covers Oramed,s ... GLP-1 is an incretin hormone that ...
Breaking Medicine Technology: